DKK3 and glioblastoma: With the aid of TCGA, we recently showed that dickkopf-3 (DKK3) in the Wnt/β-catenin signaling pathway is associated with an immunosuppressive tumor microenvironment and a poor prognosis in patients with GBM (4).